FDA panel advises clinical trial, revised labeling of fenofibric acid
Links shared publicly online about this topic.
- 281total visits
FDA panel advises clinical trial, revised labeling of fenofibric acid
The FDA Endocrinologic and Metabolic Drugs Advisory Committee unanimously recommended a clinical trial to assess the cardiovascular benefits of adding
View full resource at endocrinetoday.com
Tags: Heart, Metabolic, Drug, Clinical Trial, FDA
Most Recently Shared on May 19, 2011 at 8:34 pm By:
The votes are in! #FDA panel advises clinical trial, revised labeling of #fenofibric acid http://bit.ly/iJ0ViM
Advertisement
